Education
About Us
Working with TipRanks
Follow Us
Viemed Healthcare US (VMD)
:VMD
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.09Last Year’s EPS
0.04Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: -5.50%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Positive
The earnings call indicates a positive outlook for Viemed Healthcare, with strong financial performance, effective sales restructuring, and strategic acquisitions driving future growth. However, there are some challenges related to regulatory changes, declining gross margins, and stalled VA opportunities.Company Guidance
In the first quarter of 2025, Viemed Healthcare reported robust financial and operational performance, surpassing initial expectations. The company's vent business, representing 54% of revenues, showed a 10% year-over-year increase despite a 3% sequential decline, with total vent patients rising for the 16th consecutive quarter and new patient starts increasing by 9% sequentially. The sleep business also experienced growth, with a 7% sequential and 46% year-over-year increase in sleep therapy patients, complemented by a 40% rise in new patient setups year-over-year. The staffing business contributed 10% to net revenues, reflecting strong demand. Viemed projected full-year 2025 net revenues between $254 million and $265 million, with adjusted EBITDA expected to grow 11% over 2024, ranging from $54 million to $58 million. The company also announced the strategic acquisition of Lehan's Medical Equipment for $26 million, aiming to expand its respiratory and women's health offerings and establish a stronger presence in the Chicago market.Strong Financial Performance
Organic revenue increased by 14.5%, and total revenue increased by 16.9%. Adjusted EBITDA grew 26% for the quarter to $12.8 million, with an adjusted EBITDA margin of 21.6%, up 160 basis points from a year ago.
Vent and Sleep Business Growth
Vent revenue was only down 3% sequentially but up 10% year-over-year. The sleep business saw a 7% sequential increase in sleep therapy patients and a 46% increase year-over-year.
Acquisition of Lehan's Medical Equipment
Viemed signed an agreement to acquire Lehan's Medical Equipment for $26 million, expanding their reach in respiratory and women's health markets.
Effective Sales Restructuring
The sales restructuring implemented last year resulted in a 9% sequential increase in new patient starts for vent patients and an overall positive impact on future business results.
Positive Regulatory Environment
Recent regulatory changes, such as the CMS proposed national policy coverage determination on noninvasive positive pressure ventilation, are viewed as moving in the right direction.
---
VMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
VMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2025 | $7.27 | $6.42 | -11.69% |
Mar 10, 2025 | $7.40 | $7.80 | +5.41% |
Nov 06, 2024 | $9.14 | $9.00 | -1.53% |
Aug 07, 2024 | $6.53 | $7.18 | +9.95% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Viemed Healthcare US (VMD) report earnings?
Viemed Healthcare US (VMD) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Viemed Healthcare US (VMD) earnings time?
Viemed Healthcare US (VMD) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VMD EPS forecast?
VMD EPS forecast for the fiscal quarter 2025 (Q2) is 0.09.
---
